Nath Bio-Genes (India) Balance Sheet
- Market cap
- ₹261 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹98.91 – ₹185.45
As of FY25, Nath Bio-Genes (India) had total assets of ₹170 crore and borrowings of ₹31.33 crore, against shareholders' equity of ₹237 crore — a debt-to-equity ratio of 0.35.
Nath Bio-Genes (India) balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 117 |
| Borrowings | 31.33 |
| Other liabilities | 20.88 |
| Total liabilities | 170 |
| Fixed assets | 91.37 |
| Capital work in progress | 45 |
| Investments | 39.16 |
| Other assets | 39.16 |
| Total assets | 170 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹48.20
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Nath Bio-Genes (India) balance sheet — frequently asked questions
What is the total debt of Nath Bio-Genes (India)?
Nath Bio-Genes (India) reported borrowings of ₹31.33 crore as of FY25.
What is Nath Bio-Genes (India)'s debt-to-equity ratio?
Based on the FY25 balance sheet, Nath Bio-Genes (India)'s debt-to-equity ratio is 0.35 — borrowings of ₹31.33 crore against equity capital and reserves of ₹237 crore.
What are Nath Bio-Genes (India)'s total assets?
Nath Bio-Genes (India)'s total assets were ₹170 crore as of FY25, including fixed assets of ₹91.37 crore and investments of ₹39.16 crore.
What is the book value per share of Nath Bio-Genes (India)?
The book value per share of Nath Bio-Genes (India) is ₹48.20, based on the latest reported balance sheet.
Same Data For Peers
Trade Nath Bio-Genes (India) With ATS
Track NATHBIOGEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.